159 related articles for article (PubMed ID: 10921397)
1. Long-term effects of interferon therapy on histology and development of hepatocellular carcinoma in hepatitis C.
Omata M; Shiratori Y
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E134-40. PubMed ID: 10921397
[TBL] [Abstract][Full Text] [Related]
2. [Histological findings in the liver in patients with chronic hepatitis C].
Takase K; Shiraki K
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):434-8. PubMed ID: 15359838
[No Abstract] [Full Text] [Related]
3. The impact of antiviral therapy on the course of chronic HCV infection. A systematic review.
Almasio PL; Venezia G; Craxì A
Panminerva Med; 2003 Sep; 45(3):175-82. PubMed ID: 14618115
[TBL] [Abstract][Full Text] [Related]
4. Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.
Janjua NZ; Chong M; Kuo M; Woods R; Wong J; Yoshida EM; Sherman M; Butt ZA; Samji H; Cook D; Yu A; Alvarez M; Tyndall M; Krajden M
J Hepatol; 2017 Mar; 66(3):504-513. PubMed ID: 27818234
[TBL] [Abstract][Full Text] [Related]
5. Interferon-induced prolonged biochemical response reduces hepatocarcinogenesis in hepatitis C virus infection.
Arase Y; Ikeda K; Suzuki F; Suzuki Y; Kobayashi M; Akuta N; Hosaka T; Sezaki H; Yatsuji H; Kawamura Y; Kobayashi M; Kumada H
J Med Virol; 2007 Oct; 79(10):1485-90. PubMed ID: 17705189
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcomes of chronic hepatitis C patients with sustained virological response at 6 months after the end of treatment.
Chavalitdhamrong D; Tanwandee T
World J Gastroenterol; 2006 Sep; 12(34):5532-5. PubMed ID: 17006994
[TBL] [Abstract][Full Text] [Related]
7. Lower incidence of hepatic failure than hepatocellular carcinoma in Japanese patients with chronic hepatitis C.
Imazeki F; Yokosuka O; Fukai K; Kawai S; Kanda T; Kojima H; Saisho H
Liver Int; 2005 Aug; 25(4):772-8. PubMed ID: 15998428
[TBL] [Abstract][Full Text] [Related]
8. [Effects of IFN therapy on incidence of hepatocellular carcinoma in HCV positive cirrhosis].
Nishiguchi S; Kubo S; Shiomi S
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):600-4. PubMed ID: 15359868
[No Abstract] [Full Text] [Related]
9. Predictors of the efficacy of interferon therapy for patients with chronic hepatitis C before and during therapy: how does this modify the treatment course?
Shiratori Y; Omata M
J Gastroenterol Hepatol; 2000 May; 15 Suppl():E141-51. PubMed ID: 10921398
[TBL] [Abstract][Full Text] [Related]
10. Prevention of hepatocellular carcinoma and its recurrence in chronic hepatitis C patients by interferon therapy.
Omata M; Yoshida H; Shiratori Y
Clin Gastroenterol Hepatol; 2005 Oct; 3(10 Suppl 2):S141-3. PubMed ID: 16234063
[TBL] [Abstract][Full Text] [Related]
11. Dynamic noninvasive markers predict hepatocellular carcinoma in chronic hepatitis C patients without sustained virological response after interferon-based therapy: Prioritize who needs urgent direct-acting antiviral agents.
Huang CM; Hu TH; Chang KC; Tseng PL; Lu SN; Chen CH; Wang JH; Lee CM; Tsai MC; Lin MT; Yen YH; Hung CH; Cho CL; Wu CK
Medicine (Baltimore); 2017 Nov; 96(46):e8696. PubMed ID: 29145306
[TBL] [Abstract][Full Text] [Related]
12. Role of antiviral therapy in the prevention of hepatocellular carcinoma.
Franco J; Saeian K
J Vasc Interv Radiol; 2002 Sep; 13(9 Pt 2):S191-6. PubMed ID: 12354836
[TBL] [Abstract][Full Text] [Related]
13. Effects of interferon treatment on development and progression of hepatocellular carcinoma in patients with chronic virus infection: a meta-analysis of randomized controlled trials.
Zhang CH; Xu GL; Jia WD; Li JS; Ma JL; Ge YS
Int J Cancer; 2011 Sep; 129(5):1254-64. PubMed ID: 21710498
[TBL] [Abstract][Full Text] [Related]
14. [Chronic hepatitis C in hemodialysis patients].
Tanaka H; Ueda H; Ichinose M; Miyano M
Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):645-8. PubMed ID: 15359877
[No Abstract] [Full Text] [Related]
15. Favorable Prognosis in Patients with Sustained Virological Response to Antiviral Therapy, Including Interferon, for Chronic Hepatitis C Before Hepatic Resection for Hepatocellular Carcinoma.
Shirabe K; Sugimachi K; Harada N; Kayashima H; Maeda T; Tsujita E; Minagawa R; Kajiyama K; Yoshiya S; Maehara Y
Anticancer Res; 2015 Dec; 35(12):6963-9. PubMed ID: 26637923
[TBL] [Abstract][Full Text] [Related]
16. Hepatocellular carcinoma after sustained response to interferon in non-cirrhotic hepatitis C: flaws in the cure, or a clue to the flaws?
Farrell GC
J Gastroenterol Hepatol; 1999 Sep; 14(9):833-7. PubMed ID: 10535462
[No Abstract] [Full Text] [Related]
17. Viral eradication reduces all-cause mortality, including non-liver-related disease, in patients with progressive hepatitis C virus-related fibrosis.
Tada T; Kumada T; Toyoda H; Kiriyama S; Tanikawa M; Hisanaga Y; Kanamori A; Kitabatake S; Yama T; Tanaka J
J Gastroenterol Hepatol; 2017 Mar; 32(3):687-694. PubMed ID: 27577675
[TBL] [Abstract][Full Text] [Related]
18. Two Cases of Hepatocellular Carcinoma Arising Over 20 Years after a Sustained Virologic Response Following Interferon Therapy for Chronic Hepatitis C.
Takata K; Ishii F; Uchida Y; Fukuda H; Yamauchi R; Umeda K; Tsuchiya N; Tanaka T; Yokoyama K; Morihara D; Takeyama Y; Shakado S; Sakisaka S; Hirai F
Intern Med; 2020 Aug; 59(15):1855-1860. PubMed ID: 32350199
[TBL] [Abstract][Full Text] [Related]
19. [Hepatocellular carcinoma occurring after 11 year-long sustained viral response to interferon therapy for chronic hepatitis C].
Suganami F; Tomiyama Y; Ohmoto K; Kawase T; Yoshioka N; Shibata N; Yoshida K; Kuboki M; Yamamoto S
Nihon Shokakibyo Gakkai Zasshi; 2007 Jun; 104(6):809-14. PubMed ID: 17548948
[TBL] [Abstract][Full Text] [Related]
20. Long-term effects of interferon-based therapy for chronic hepatitis C.
Yu ML; Huang CF; Dai CY; Huang JF; Chuang WL
Oncology; 2007; 72 Suppl 1():16-23. PubMed ID: 18087178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
